S
Stan Z. Gertler
Researcher at University of Ottawa
Publications - 21
Citations - 591
Stan Z. Gertler is an academic researcher from University of Ottawa. The author has contributed to research in topics: Chemotherapy & Breast cancer. The author has an hindex of 11, co-authored 21 publications receiving 553 citations. Previous affiliations of Stan Z. Gertler include Ottawa Hospital.
Papers
More filters
Journal ArticleDOI
A selective N-type Ca(2+)-channel blocker prevents CA1 injury 24 h following severe forebrain ischemia and reduces infarction following focal ischemia
Alastair M. Buchan,Stan Z. Gertler,Hui Li,Dong Xue,Zhi-Gao Huang,Karen E. Chaundy,Kimberley Barnes,Howard Lesiuk +7 more
TL;DR: Ca2+ fluxes through ω-conopeptide-sensitive N-type Ca2+ channels are critically involved in the pathogenesis of selective neuronal death up to 24 h after ischemia in the hippocampus and that this conopeptid protection extends, even when given late, to neocortical infarct reduction.
Journal ArticleDOI
Use of trastuzumab beyond disease progression: observations from a retrospective review of case histories.
Karen A. Gelmon,John R. Mackey,Shailendra Verma,Stan Z. Gertler,Nicholas Bangemann,Paul Klimo,Andreas Schneeweiss,Karl Bremer,Denis Soulières,Katia Tonkin,Richard Bell,Bernhard Heinrich,Debjani Grenier,Reg Dias +13 more
TL;DR: Trastuzumab treatment beyond progression appears to be of value, producing responses and clinical benefit, and is well tolerated without significant cardiac toxicity, and the feasibility of this approach warrants examination in prospective trials.
Journal ArticleDOI
Use of Conjoint Analysis to Assess Breast Cancer Patient Preferences for Chemotherapy Side Effects
Kathleen Beusterien,Jessica Grinspan,Iryna Kuchuk,Sasha Mazzarello,Susan Dent,Stan Z. Gertler,Nathaniel Bouganim,Lisa Vandermeer,Mark Clemons +8 more
TL;DR: In this paper, the authors evaluated preferences associated with grade I/II and grade III/IV chemotherapy side effects among breast cancer patients receiving chemotherapy and assessed trade-offs that patients are willing to make between treatment side effects and the route and schedule of treatment administration.
Journal ArticleDOI
Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase
TL;DR: High dose nitro-arginine caused an increase in hypertension in the spontaneously hypertensive rats and increased the severity of focal ischemia as measured by intra-ischemic regional cerebral blood flows.
Journal ArticleDOI
The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study.
Dominique Frechette,Lise Paquet,Shailendra Verma,Mark Clemons,Paul Wheatley-Price,Stan Z. Gertler,Xinni Song,N. Graham,Susan Dent +8 more
TL;DR: The observation that SF remained stable across time is encouraging news, however, longer follow-up and the inclusion of women who were premenopausal at diagnosis are needed to determine the potential influence of extended duration of ET on SD.